News | Stroke | April 06, 2017

San Clemente Physician Successfully Treats Stroke Patients With Hyperbaric Oxygen

Treatment activates neuroplasticity and improves stroke-induced neurologic deficiencies

hyperbaric oxygen treatment, HBOT, stroke, David Steenblock D.O.

Image courtesy of David Steenblock, D.O.


April 6, 2017 — David Steenblock, D.O., an osteopathic physician based in San Clemente, Calif., recently discussed his use of hyperbaric oxygen to achieve significant and improved lifestyle outcomes for many stroke patients. The technique involves the therapeutic use of oxygen under pressure to dramatically reduce the effects of stroke and brain injury.

“Many of our cases have demonstrated a 40-100 percent rate of improvement for stroke victims who received oxygen under pressure, “ said Steenblock. He encourages U.S. physicians to consider the merits of this approach.

Steenblock treated a 62-year old patient with a stroke that completely paralyzed her right arm and left her severally bent over and limping, He prescribed his patient a series of 60 treatments within 12 weeks in a hyperbaric oxygen chamber. Increasing a person’s level of dissolved oxygen using HBOT can activate neuroplasticity and improve stroke-induced neurologic deficiencies, he added.

The goal is to get as much oxygen into the brain as possible. This helps to revive oxygen-starved, damaged brain tissue, Steenblock explained. This principle holds true for traumatic brain injury as well, where brain tissue is irreversibly destroyed, as brain cells deprived of oxygen usually die within 10 minutes, but a larger portion is potentially revivable.

After one month of treatment, the patient showed clear signs of improvement, with walking, posture and range of motion noticeably improved. She was able to open and close her right hand, grip and squeeze objects, and raise her arm to her chest.

For more information: www.stemcellmd.org


Related Content

News | Stroke

March 3, 2025 — Genentech, a member of the Roche Group, recently announced that the U.S. Food and Drug Administration ...

Home March 04, 2025
Home
News | Stroke

Feb. 6, 2025 — New findings from the DiVERT Stroke clinical study showed women spent less time in the hospital, saw ...

Home February 07, 2025
Home
News | Stroke

Feb. 5, 2025 — Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment ...

Home February 07, 2025
Home
News | Stroke

Jan. 29, 2025 — Researchers at Ochsner Health, led by Hernan Bazan, MD, DFSVS, FACS, have developed a predictive model ...

Home January 30, 2025
Home
News | Stroke

Nov. 16, 2024 Anthos Therapeutics, Inc.recently presented new data at the American Heart Association (AHA) Scientific ...

Home November 18, 2024
Home
News | Stroke

Oct. 24, 2024 – Royal Philips and Medtronic Neurovascular have announced a strategic advocacy partnership. Delivering ...

Home October 24, 2024
Home
News | Stroke

Sept. 10, 2024 — Royal Philips and the World Stroke Organization (WSO) have published a policy paper calling for a ...

Home September 10, 2024
Home
News | Stroke

Aug. 23, 2024 — A team led by researchers at Yale School of Medicine has created a deep learning model that can ...

Home August 26, 2024
Home
News | Stroke

According to research published in Stroke, the peer-reviewed scientific journal of the American Stroke Association, one ...

Home August 09, 2024
Home
News | Stroke

June 7, 2024 — Access to thrombectomy should be expanded to include patients who experience basilar artery occlusion ...

Home June 07, 2024
Home
Subscribe Now